Worldwide Clinical Trials Executive and Leadership Team

November, 2026

Leadership Overview

Worldwide Clinical Trials has 5 executives leading key functions including information technology, financial planning, global clinical development, human resources, and oncology research.

Committed to advancing medical breakthroughs, Worldwide Clinical Trials delivers comprehensive preclinical and Phase I-IV clinical development services to global biotechnology and pharmaceutical partners.

Leadership Roles at Worldwide Clinical Trials

  • President, Oncology - Keya Watkins
  • Chief Information Officer - Deborah Jones-Hertzog
  • Senior Manager - Global FP & A for A 600M PE Backed Chief Revenue Officer Company - Stephen Grayauskie
  • Chief Of Staff, GCD - Lisa Skorets
  • Chief People Officer - Joy Clark
  • Keya Watkins - President, Oncology

    Keya Watkins, the President, Oncology at Worldwide Clinical Trials, leads the strategic direction and execution of oncology-focused clinical development programs. Watkins oversees the design and implementation of complex Phase I-IV trials, ensuring that research protocols meet the specific needs of pharmaceutical partners. By driving innovation in cancer research, the President, Oncology expands the company's footprint in the competitive oncology market. This leadership role involves coordinating with global research teams to deliver high-quality data for oncology studies. Keya Watkins directs the integration of real-world evidence into clinical development strategies to improve patient outcomes. Through the management of therapeutic-specific resources, the President, Oncology ensures that oncology projects receive the necessary expertise and focus. By fostering relationships with key stakeholders, Watkins supports the growth of the oncology portfolio. Ultimately, Watkins drives the success of critical cancer research initiatives through expert leadership and strategic oversight.

    Deborah Jones-Hertzog - Chief Information Officer

    Deborah Jones-Hertzog, the Chief Information Officer at Worldwide Clinical Trials, directs the digital infrastructure supporting complex clinical research operations. Jones-Hertzog architects secure data management systems essential for Phase I-IV trials, ensuring compliance with global regulatory standards across diverse therapeutic areas. By integrating advanced analytics into the clinical development lifecycle, the Chief Information Officer optimizes data flow between research sites and pharmaceutical sponsors. This leadership role involves overseeing cybersecurity protocols to protect sensitive patient information while maintaining high-performance computing environments for bioanalytical sciences. Deborah Jones-Hertzog drives technological innovation to accelerate study timelines and improve data integrity. Through the implementation of scalable cloud solutions, the Chief Information Officer supports the company's mission to provide top-performing research services. Ultimately, Jones-Hertzog secures the digital foundation necessary for successful global clinical development programs.

    Stephen Grayauskie - Senior Manager - Global FP & A for A 600M PE Backed Chief Revenue Officer Company

    Stephen Grayauskie, the Senior Manager - Global FP & A for A 600M PE Backed Chief Revenue Officer Company at Worldwide Clinical Trials, manages financial forecasting and strategic resource allocation. Grayauskie analyzes complex revenue streams across preclinical and late-phase clinical studies to ensure fiscal health. By monitoring global market trends, the Senior Manager - Global FP & A for A 600M PE Backed Chief Revenue Officer Company aligns budgetary goals with the company's expansion objectives in the biotechnology sector. This role involves collaborating with executive leadership to evaluate the financial viability of new therapeutic research initiatives. Stephen Grayauskie drives operational efficiency by identifying cost-saving opportunities within the clinical development service model. Through rigorous financial modeling, the Senior Manager - Global FP & A for A 600M PE Backed Chief Revenue Officer Company supports long-term growth and investment strategies. Ultimately, Grayauskie maintains the financial stability required for sustained innovation.

    Lisa Skorets - Chief Of Staff, GCD

    Lisa Skorets, the Chief Of Staff, GCD at Worldwide Clinical Trials, coordinates strategic initiatives across the global clinical development division. Skorets facilitates communication between departmental leaders to ensure seamless execution of Phase I-IV trials. By streamlining internal processes, the Chief Of Staff, GCD enhances the efficiency of research delivery for pharmaceutical and biotechnology clients. This leadership role involves managing cross-functional projects that span cardiovascular, metabolic, and neuroscience therapeutic areas. Lisa Skorets drives organizational alignment by translating high-level corporate strategy into actionable operational plans. Through the oversight of key development milestones, the Chief Of Staff, GCD supports the timely delivery of real-world evidence and post-approval studies. By fostering collaboration among research teams, Skorets ensures that the company maintains its reputation for excellence in clinical development. Ultimately, Skorets optimizes the internal framework to support complex global research operations.

    Joy Clark - Chief People Officer

    Joy Clark, the Chief People Officer at Worldwide Clinical Trials, directs human capital strategy to attract and retain top-tier talent in the clinical research industry. Clark designs comprehensive programs for professional development and organizational culture, ensuring alignment with the company's mission of advancing medical science. By overseeing global recruitment and employee engagement initiatives, the Chief People Officer builds high-performing teams capable of managing complex Phase I-IV clinical trials. This leadership role involves partnering with executive management to foster an inclusive environment that supports innovation in oncology and rare disease research. Joy Clark drives talent management strategies that enhance operational capacity across international markets. Through the implementation of robust performance management systems, the Chief People Officer supports the professional growth of researchers and clinical staff. Ultimately, Clark secures the human resources necessary to maintain the company's competitive edge in the global CRO market.
    Joy Clark

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding Worldwide Clinical Trials Top Executives and Leadership Team

    Who leads Worldwide Clinical Trials?
    Worldwide Clinical Trials is led by Keya Watkins (President, Oncology), along with executives such as Deborah Jones-Hertzog (Chief Information Officer) and Stephen Grayauskie (Senior Manager - Global FP & A for A 600M PE Backed Chief Revenue Officer Company).
    Who is part of Worldwide Clinical Trials’s executive team?
    The executive team of Worldwide Clinical Trials includes leaders such as Keya Watkins (President, Oncology), Deborah Jones-Hertzog (Chief Information Officer), Stephen Grayauskie (Senior Manager - Global FP & A for A 600M PE Backed Chief Revenue Officer Company) and other senior executives.
    How many executives does Worldwide Clinical Trials have?
    Worldwide Clinical Trials has 5 executives leading key business areas.
    What roles are included in Worldwide Clinical Trials’s leadership team?
    The leadership team of Worldwide Clinical Trials includes roles such as President, Oncology, Chief Information Officer, Senior Manager - Global FP & A for A 600M PE Backed Chief Revenue Officer Company, Chief Of Staff, GCD, Chief People Officer.